Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
125 tokens/sec
GPT-4o
53 tokens/sec
Gemini 2.5 Pro Pro
42 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
47 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Diabetic Retinopathy Detection using Ensemble Machine Learning (2106.12545v1)

Published 22 Jun 2021 in eess.IV, cs.CV, and cs.LG

Abstract: Diabetic Retinopathy (DR) is among the worlds leading vision loss causes in diabetic patients. DR is a microvascular disease that affects the eye retina, which causes vessel blockage and therefore cuts the main source of nutrition for the retina tissues. Treatment for this visual disorder is most effective when it is detected in its earliest stages, as severe DR can result in irreversible blindness. Nonetheless, DR identification requires the expertise of Ophthalmologists which is often expensive and time-consuming. Therefore, automatic detection systems were introduced aiming to facilitate the identification process, making it available globally in a time and cost-efficient manner. However, due to the limited reliable datasets and medical records for this particular eye disease, the obtained predictions accuracies were relatively unsatisfying for eye specialists to rely on them as diagnostic systems. Thus, we explored an ensemble-based learning strategy, merging a substantial selection of well-known classification algorithms in one sophisticated diagnostic model. The proposed framework achieved the highest accuracy rates among all other common classification algorithms in the area. 4 subdatasets were generated to contain the top 5 and top 10 features of the Messidor dataset, selected by InfoGainEval. and WrapperSubsetEval., accuracies of 70.7% and 75.1% were achieved on the InfoGainEval. top 5 and original dataset respectively. The results imply the impressive performance of the subdataset, which significantly conduces to a less complex classification process

Citations (19)

Summary

We haven't generated a summary for this paper yet.